
Nkarta, Inc. (NKTX) Dividend History
Nkarta, Inc. is a biotechnology company focused on developing allogeneic CAR NK (natural killer) cell therapies for cancer treatment. Leveraging its proprietary cell engineering platform, Nkarta aims to create off-the-shelf immunotherapies to improve efficacy and safety for patients with various cancers.
1150 Veterans Boulevard, South San Francisco, CA, 94080
Phone: (925) 407-1049
Website: https://www.nkartatx.com
Phone: (925) 407-1049
Website: https://www.nkartatx.com
Dividend History
Nkarta, Inc. currently does not pay dividends
Company News
-
GlobeNewswire Inc.
-
GlobeNewswire Inc.
-
GlobeNewswire Inc.
-
The Motley Fool